Malaysia is expected to receive the first batch of the COVID-19 vaccine jointly developed by Pfizer and BioNTech in February next year. This fact sheet contains information to help you understand the risks and benefits of the Pfizer-BioNTech COVID-19 Vaccine.
Category: Fact sheets
[FACT SHEETS] Understanding the stability of COVID-19
ASM has established a Special Interest Group (SIG) on COVID-19 comprising of Fellows of the Academy to review key research findings around the world and issue fact sheets to help the public understand the implications and limitations of the research studies.
You must be logged in to post a comment.